These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29192688)

  • 1. Fluoridation and attention deficit hyperactivity disorder - a critique of Malin and Till (2015).
    Perrott KW
    Br Dent J; 2018 Jan; 223(11):819-822. PubMed ID: 29192688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to fluoridated water and attention deficit hyperactivity disorder prevalence among children and adolescents in the United States: an ecological association.
    Malin AJ; Till C
    Environ Health; 2015 Feb; 14():17. PubMed ID: 25890329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of water fluoride and urinary fluoride concentrations with attention deficit hyperactivity disorder in Canadian youth.
    Riddell JK; Malin AJ; Flora D; McCague H; Till C
    Environ Int; 2019 Dec; 133(Pt B):105190. PubMed ID: 31654913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in household income and risk for attention deficit hyperactivity disorder during childhood: A nationwide population-based cohort study.
    Choi Y; Shin J; Cho KH; Park EC
    J Epidemiol; 2017 Feb; 27(2):56-62. PubMed ID: 28142012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Altitude and Regional Variation of ADHD in Youth.
    Huber RS; Kim TS; Kim N; Kuykendall MD; Sherwood SN; Renshaw PF; Kondo DG
    J Atten Disord; 2018 Dec; 22(14):1299-1306. PubMed ID: 25808310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family income in early childhood and subsequent attention deficit/hyperactivity disorder: a quasi-experimental study.
    Larsson H; Sariaslan A; Långström N; D'Onofrio B; Lichtenstein P
    J Child Psychol Psychiatry; 2014 May; 55(5):428-35. PubMed ID: 24111650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water fluoridation and osteoporotic fracture.
    Hillier S; Inskip H; Coggon D; Cooper C
    Community Dent Health; 1996 Sep; 13 Suppl 2():63-8. PubMed ID: 8897754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.
    Froehlich TE; Lanphear BP; Epstein JN; Barbaresi WJ; Katusic SK; Kahn RS
    Arch Pediatr Adolesc Med; 2007 Sep; 161(9):857-64. PubMed ID: 17768285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of attention-deficit/hyperactivity disorder symptoms and their associations with sleep schedules and sleep-related problems among preschoolers in mainland China.
    Cao H; Yan S; Gu C; Wang S; Ni L; Tao H; Shao T; Xu Y; Tao F
    BMC Pediatr; 2018 Feb; 18(1):70. PubMed ID: 29458356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between diagnosed ADHD and selected characteristics among children aged 4-17 years: United States, 2011-2013.
    Pastor P; Reuben C; Duran C; Hawkins L
    NCHS Data Brief; 2015 May; (201):201. PubMed ID: 25974000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of attention deficit hyperactivity disorder with socioeconomic disadvantage: alternative explanations and evidence.
    Russell G; Ford T; Rosenberg R; Kelly S
    J Child Psychol Psychiatry; 2014 May; 55(5):436-45. PubMed ID: 24274762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Sociodemographic Factors Associated With Attention-Deficit/Hyperactivity Disorder in Patients With Cystic Fibrosis.
    Eworuke E; Zeng QY; Winterstein AG
    Psychosomatics; 2015; 56(5):495-503. PubMed ID: 25620567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(44):1439-43. PubMed ID: 21063274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children.
    Modesto T; Tiemeier H; Peeters RP; Jaddoe VW; Hofman A; Verhulst FC; Ghassabian A
    JAMA Pediatr; 2015 Sep; 169(9):838-45. PubMed ID: 26146876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations Between Adverse Childhood Experiences and ADHD Diagnosis and Severity.
    Brown NM; Brown SN; Briggs RD; Germán M; Belamarich PF; Oyeku SO
    Acad Pediatr; 2017; 17(4):349-355. PubMed ID: 28477799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoride exposure and reported learning disability diagnosis among Canadian children: Implications for community water fluoridation.
    Barberio AM; Quiñonez C; Hosein FS; McLaren L
    Can J Public Health; 2017 Sep; 108(3):e229-e239. PubMed ID: 28910243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental risk factors for attention-deficit hyperactivity disorder.
    Banerjee TD; Middleton F; Faraone SV
    Acta Paediatr; 2007 Sep; 96(9):1269-74. PubMed ID: 17718779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.